
### [MONDO:0006322](http://purl.obolibrary.org/obo/MONDO_0006322)
**Label:** non-neoplastic bile duct disorder

**Subclasses:** [MONDO:0018646](http://purl.obolibrary.org/obo/MONDO_0018646) (sclerosing cholangitis (disease)), [MONDO:0001929](http://purl.obolibrary.org/obo/MONDO_0001929) (ascending cholangitis), [MONDO:0018647](http://purl.obolibrary.org/obo/MONDO_0018647) (secondary sclerosing cholangitis), [MONDO:0013433](http://purl.obolibrary.org/obo/MONDO_0013433) (primary sclerosing cholangitis), [MONDO:0018645](http://purl.obolibrary.org/obo/MONDO_0018645) (IgG4-related sclerosing cholangitis), [MONDO:0011199](http://purl.obolibrary.org/obo/MONDO_0011199) (nephropathy, progressive tubulointerstitial, with cholestatic liver disease), [MONDO:0001928](http://purl.obolibrary.org/obo/MONDO_0001928) (suppurative cholangitis), [MONDO:0008867](http://purl.obolibrary.org/obo/MONDO_0008867) (biliary atresia), [MONDO:0001931](http://purl.obolibrary.org/obo/MONDO_0001931) (pericholangitis), [MONDO:0004789](http://purl.obolibrary.org/obo/MONDO_0004789) (cholangitis), [MONDO:0006757](http://purl.obolibrary.org/obo/MONDO_0006757) (extrahepatic cholestasis), [MONDO:0001930](http://purl.obolibrary.org/obo/MONDO_0001930) (acute cholangitis), [MONDO:0004786](http://purl.obolibrary.org/obo/MONDO_0004786) (chronic cholangitis), [MONDO:0002155](http://purl.obolibrary.org/obo/MONDO_0002155) (cholecystitis), [MONDO:0004875](http://purl.obolibrary.org/obo/MONDO_0004875) (xanthogranulomatous cholecystitis), [MONDO:0006633](http://purl.obolibrary.org/obo/MONDO_0006633) (acalculous cholecystitis), [MONDO:0010913](http://purl.obolibrary.org/obo/MONDO_0010913) (Caroli disease), [MONDO:0006874](http://purl.obolibrary.org/obo/MONDO_0006874) (obstructive jaundice), [MONDO:0005742](http://purl.obolibrary.org/obo/MONDO_0005742) (emphysematous cholecystitis), [MONDO:0010939](http://purl.obolibrary.org/obo/MONDO_0010939) (low phospholipid associated cholelithiasis), [MONDO:0011874](http://purl.obolibrary.org/obo/MONDO_0011874) (neonatal ichthyosis-sclerosing cholangitis syndrome), [MONDO:0018816](http://purl.obolibrary.org/obo/MONDO_0018816) (isolated neonatal sclerosing cholangitis), 

**Mapped go classes:** [GO:0016887](http://purl.obolibrary.org/obo/GO_0016887) (ATPase activity), [GO:0061772](http://purl.obolibrary.org/obo/GO_0061772) (drug transport across blood-nerve barrier), [GO:0016328](http://purl.obolibrary.org/obo/GO_0016328) (lateral plasma membrane), [GO:0008065](http://purl.obolibrary.org/obo/GO_0008065) (establishment of blood-nerve barrier), [GO:0005198](http://purl.obolibrary.org/obo/GO_0005198) (structural molecule activity), [GO:0000139](http://purl.obolibrary.org/obo/GO_0000139) (Golgi membrane), [GO:0051291](http://purl.obolibrary.org/obo/GO_0051291) (protein heterooligomerization), [GO:0009636](http://purl.obolibrary.org/obo/GO_0009636) (response to toxic substance), [GO:0046581](http://purl.obolibrary.org/obo/GO_0046581) (intercellular canaliculus), [GO:0045332](http://purl.obolibrary.org/obo/GO_0045332) (phospholipid translocation), [GO:0015629](http://purl.obolibrary.org/obo/GO_0015629) (actin cytoskeleton), [GO:0005829](http://purl.obolibrary.org/obo/GO_0005829) (cytosol), [GO:2001140](http://purl.obolibrary.org/obo/GO_2001140) (positive regulation of phospholipid transport), [GO:0042626](http://purl.obolibrary.org/obo/GO_0042626) (ATPase activity, coupled to transmembrane movement of substances), [GO:0015562](http://purl.obolibrary.org/obo/GO_0015562) (efflux transmembrane transporter activity), [GO:0051260](http://purl.obolibrary.org/obo/GO_0051260) (protein homooligomerization), [GO:1903413](http://purl.obolibrary.org/obo/GO_1903413) (cellular response to bile acid), [GO:0008559](http://purl.obolibrary.org/obo/GO_0008559) (xenobiotic transmembrane transporting ATPase activity), [GO:0006810](http://purl.obolibrary.org/obo/GO_0006810) (transport), [GO:1901557](http://purl.obolibrary.org/obo/GO_1901557) (response to fenofibrate), [GO:0005886](http://purl.obolibrary.org/obo/GO_0005886) (plasma membrane), [GO:0045216](http://purl.obolibrary.org/obo/GO_0045216) (cell-cell junction organization), [GO:0005515](http://purl.obolibrary.org/obo/GO_0005515) (protein binding), [GO:0070673](http://purl.obolibrary.org/obo/GO_0070673) (response to interleukin-18), [GO:0061092](http://purl.obolibrary.org/obo/GO_0061092) (positive regulation of phospholipid translocation), [GO:0070830](http://purl.obolibrary.org/obo/GO_0070830) (bicellular tight junction assembly), [GO:0030054](http://purl.obolibrary.org/obo/GO_0030054) (cell junction), [GO:0016323](http://purl.obolibrary.org/obo/GO_0016323) (basolateral plasma membrane), [GO:0016324](http://purl.obolibrary.org/obo/GO_0016324) (apical plasma membrane), [GO:0090557](http://purl.obolibrary.org/obo/GO_0090557) (establishment of endothelial intestinal barrier), [GO:0090554](http://purl.obolibrary.org/obo/GO_0090554) (phosphatidylcholine-translocating ATPase activity), [GO:1903348](http://purl.obolibrary.org/obo/GO_1903348) (positive regulation of bicellular tight junction assembly), [GO:0008525](http://purl.obolibrary.org/obo/GO_0008525) (phosphatidylcholine transporter activity), [GO:0061436](http://purl.obolibrary.org/obo/GO_0061436) (establishment of skin barrier), [GO:0005654](http://purl.obolibrary.org/obo/GO_0005654) (nucleoplasm), [GO:0000166](http://purl.obolibrary.org/obo/GO_0000166) (nucleotide binding), [GO:0005524](http://purl.obolibrary.org/obo/GO_0005524) (ATP binding), [GO:0005887](http://purl.obolibrary.org/obo/GO_0005887) (integral component of plasma membrane), [GO:0005923](http://purl.obolibrary.org/obo/GO_0005923) (bicellular tight junction), [GO:0070062](http://purl.obolibrary.org/obo/GO_0070062) (extracellular exosome), [GO:0005925](http://purl.obolibrary.org/obo/GO_0005925) (focal adhesion), [GO:0031410](http://purl.obolibrary.org/obo/GO_0031410) (cytoplasmic vesicle), [GO:0032782](http://purl.obolibrary.org/obo/GO_0032782) (bile acid secretion), [GO:0016338](http://purl.obolibrary.org/obo/GO_0016338) (calcium-independent cell-cell adhesion via plasma membrane cell-adhesion molecules), [GO:0042802](http://purl.obolibrary.org/obo/GO_0042802) (identical protein binding), [GO:0055085](http://purl.obolibrary.org/obo/GO_0055085) (transmembrane transport), [GO:0015462](http://purl.obolibrary.org/obo/GO_0015462) (ATPase-coupled protein transmembrane transporter activity), [GO:0055088](http://purl.obolibrary.org/obo/GO_0055088) (lipid homeostasis), [GO:0006869](http://purl.obolibrary.org/obo/GO_0006869) (lipid transport), [GO:0004129](http://purl.obolibrary.org/obo/GO_0004129) (cytochrome-c oxidase activity), [GO:0005737](http://purl.obolibrary.org/obo/GO_0005737) (cytoplasm), [GO:0016020](http://purl.obolibrary.org/obo/GO_0016020) (membrane), [GO:0016021](http://purl.obolibrary.org/obo/GO_0016021) (integral component of membrane), [GO:0055114](http://purl.obolibrary.org/obo/GO_0055114) (oxidation-reduction process), [GO:0001618](http://purl.obolibrary.org/obo/GO_0001618) (virus receptor activity), [GO:0032376](http://purl.obolibrary.org/obo/GO_0032376) (positive regulation of cholesterol transport), [GO:0019534](http://purl.obolibrary.org/obo/GO_0019534) (toxin transmembrane transporter activity), [GO:0016787](http://purl.obolibrary.org/obo/GO_0016787) (hydrolase activity), 

**Class expressions from DL-Learner:**

- Thing 53.07%
- [GO:0046581](http://purl.obolibrary.org/obo/GO_0046581) (intercellular canaliculus) 52.17%
- [GO:0005925](http://purl.obolibrary.org/obo/GO_0005925) (focal adhesion) 52.17%
- [GO:0005924](http://purl.obolibrary.org/obo/GO_0005924) (cell-substrate adherens junction) 37.53%
- [GO:0030055](http://purl.obolibrary.org/obo/GO_0030055) (cell-substrate junction) and [GO:0070161](http://purl.obolibrary.org/obo/GO_0070161) (anchoring junction) 37.53%
- [GO:0005912](http://purl.obolibrary.org/obo/GO_0005912) (adherens junction) and [GO:0030055](http://purl.obolibrary.org/obo/GO_0030055) (cell-substrate junction) 37.53%
- [GO:0005924](http://purl.obolibrary.org/obo/GO_0005924) (cell-substrate adherens junction) and ([GO:0005575](http://purl.obolibrary.org/obo/GO_0005575) (cellular_component) or [GO:2001221](http://purl.obolibrary.org/obo/GO_2001221) (obsolete positive regulation of G2 phase of mitotic cell cycle)) 37.53%
- [GO:0005924](http://purl.obolibrary.org/obo/GO_0005924) (cell-substrate adherens junction) and ([GO:0005575](http://purl.obolibrary.org/obo/GO_0005575) (cellular_component) or [GO:2001220](http://purl.obolibrary.org/obo/GO_2001220) (obsolete negative regulation of G2 phase of mitotic cell cycle)) 37.53%
- [GO:0005924](http://purl.obolibrary.org/obo/GO_0005924) (cell-substrate adherens junction) and ([GO:0005575](http://purl.obolibrary.org/obo/GO_0005575) (cellular_component) or [GO:2001219](http://purl.obolibrary.org/obo/GO_2001219) (obsolete positive regulation of S/G2 transition of mitotic cell cycle)) 37.53%
- [GO:0005924](http://purl.obolibrary.org/obo/GO_0005924) (cell-substrate adherens junction) and ([GO:0005575](http://purl.obolibrary.org/obo/GO_0005575) (cellular_component) or [GO:2001218](http://purl.obolibrary.org/obo/GO_2001218) (obsolete negative regulation of S/G2 transition of mitotic cell cycle)) 37.53%
- [GO:0005924](http://purl.obolibrary.org/obo/GO_0005924) (cell-substrate adherens junction) and ([GO:0005575](http://purl.obolibrary.org/obo/GO_0005575) (cellular_component) or [GO:2001217](http://purl.obolibrary.org/obo/GO_2001217) (obsolete regulation of S/G2 transition of mitotic cell cycle)) 37.53%
- [GO:0005924](http://purl.obolibrary.org/obo/GO_0005924) (cell-substrate adherens junction) and ([GO:0005575](http://purl.obolibrary.org/obo/GO_0005575) (cellular_component) or [GO:2001052](http://purl.obolibrary.org/obo/GO_2001052) (null)) 37.53%
- [GO:0005924](http://purl.obolibrary.org/obo/GO_0005924) (cell-substrate adherens junction) and ([GO:0005575](http://purl.obolibrary.org/obo/GO_0005575) (cellular_component) or [GO:2001048](http://purl.obolibrary.org/obo/GO_2001048) (null)) 37.53%
- [GO:0005924](http://purl.obolibrary.org/obo/GO_0005924) (cell-substrate adherens junction) and ([GO:0005575](http://purl.obolibrary.org/obo/GO_0005575) (cellular_component) or [GO:2001047](http://purl.obolibrary.org/obo/GO_2001047) (null)) 37.53%
- [GO:0005924](http://purl.obolibrary.org/obo/GO_0005924) (cell-substrate adherens junction) and ([GO:0005575](http://purl.obolibrary.org/obo/GO_0005575) (cellular_component) or [GO:2001041](http://purl.obolibrary.org/obo/GO_2001041) (null)) 37.53%


